5,8-Dibromo-2,3-dimethylquinoxaline (1). To the solution of 3,6-dibromobenzene-1,2-diamine (1.33 g, 5.0 mmol) in 60 mL ethanol, diacetyl (0.65 g, 7.5 mmol) was added slowly and the resultant solution was stirred at 60°C overnight. The mixture was extracted with chloroform and then washed with water for several times. The organic phase was dried over anhydrous Na2SO4. Removal of the solvent gave a crude product, which was further purified by silica-gel column chromatography to obtain 1 as a light yellow oil (1.18 g, 75%). 1H NMR (CDCl3, 300 MHz) d (ppm): 7.84 (d, J = 2.4 Hz, 2H, ArH), 2.84 (s, 6H, -CH3).
5,8-Bis(4-hexylthiophen-2-yl)-2,3-dimethylquinoxaline (2). To a solution of compound 1 (1.18 g, 3.75 mmol) and tributyl(4-hexylthiophen-2-yl)stannane (4.28 g, 9.37 mmol) in toluene (30 mL), was added Pd(PPh3)4 (0.012 g, 0.01 mmol) under an atmosphere of nitrogen. After refluxing for 12 h, the mixture was cooled to room temperature and then poured into water, the organic layer was extracted by CH2Cl2 and dried over anhydrous Na2SO4. The crude product was purified through a silica gel chromatography column to give 2 as a yellow oil (1.67 g, 90%). 1H NMR (CDCl3, 300 MHz) d (ppm): 7.96 (br, 2H, ArH), 7.66 (s, 2H, ArH), 7.06 (s, 2H, ArH), 2.78 (s, 6H, -CH3), 2.65 (t, J = 6.9 Hz, 4H, -CH2-), 1.69-1.66(m, 4H, -CH2-), 1.34 (br, 12H, -CH2-), 0.90 (br, 6H, -CH3).
3-Hexyl-5-(8-(4-hexylthiophen-2-yl)-2,3-dimethylquinoxalin-5-yl)thiophene-2-carbaldehyde (3). DMF (0.51 g, 7.0 mmol) was added to freshly distilled POCl3 (0.54 g, 3.5 mmol) under an atmosphere of dry nitrogen at 0°C, and the resultant solution was stirred until its complete conversion into a glassy solid. After the addition of compound 2 (1.23 g, 2.5 mmol) in 1, 2-dichloroethane (30 mL) dropwise, the mixture was stirred at room temperature overnight, then poured into an aqueous solution of sodium acetate (1 M<FootNote>
</FootNote>, 200 mL), and stirred for another 2 h. The mixture was extracted with chloroform for several times, the organic fractions were combined and dried over anhydrous Na2SO4. After removing the solvent under vacuum, the crude product was purified through a silica gel chromatography column to give 3 as a red oil (0.98 g, 76%). 1H NMR (CDCl3, 300 MHz) d (ppm): 10.10 (s, 1H, -CHO), 8.04 (d, J = 8.1 Hz, 1H, ArH), 7.98 (d, J = 8.1 Hz, 1H, ArH), 7.71 (s, 1H, ArH), 7.65 (s, 1H, ArH), 7.12 (s, 1H, ArH), 3.00 (t, J = 7.2 Hz, 2H, -CH2-), 2.80 (s, 3H, -CH3), 2.79 (s, 3H, -CH3), 2.68 (t, J = 7.5 Hz, 2H, -CH2-), 1.77-1.65 (m, 4H, -CH2-), 1.43-1.34 (m, 12H, -CH2-), 0.90 (br, 6H, -CH3).
5-(8-(5-Bromo-4-hexylthiophen-2-yl)-2,3-dimethylquinoxalin-5-yl)-3-hexylthiophene-2-carbalde hyde (4). To a solution of compound 3 (0.78 g, 1.5 mmol) in CHCl3 (15 mL) was added N-bromosuccinimide (0.27 g, 1.5 mmol). This mixture was stirred for 10 h in the absence of light at room temperature and then removed the solvent under vacuum. The crude product was purified through a silica gel chromatography column to give 4 as a red solid (0.80 g, 89%). 1H NMR (CDCl3, 300 MHz) d (ppm): 10.10 (s, 1H, -CHO), 8.05 (d, J = 7.8 Hz, 1H, ArH), 8.00 (br, 1H, ArH), 7.67 (s, 1H, ArH), 7.50 (s, 1H, ArH), 3.01 (t, J = 6.6 Hz, 2H, -CH2-), 2.80 (br, 6H, -CH3), 2.63 (t, J = 7.5 Hz, 2H, -CH2-), 1.75-1.58 (m, 4H, -CH2-), 1.35 (br, 12H, -CH2-), 0.91 (br, 6H, -CH3).
General synthesis of 5. A mixture of 4 (597.0 mg, 1.0 mmol), 4-(Diphenyl amino)phenylboronic acid or 9-hexyl-9H-carbazol-3-ylboronic acid (2.0 mmol), sodium carbonate (2.12 g, 20.0 mmol), and Pd(PPh3)4 (0.012 g, 0.01 mmol) was carefully degassed and charged with nitrogen, and then dissolved in the solvent system of THF (monomer concentration about 0.025 M)/water (2:1 in volume). The reaction was stirred for 24 h at 80°C. After cooled to room temperature, the organic layer was separated, and evaporated to dryness. The crude product was purified by column chromatography over silica gel to give 5.
5-(8-(5-(4-(Diphenylamino)phenyl)-4-hexylthiophen-2-yl)-2,3-dimethylquinoxalin-5-yl)-3-hexyl thiophene-2-carbaldehyde (5a). Red solid. 0.53 g. Yield: 69%. 1H NMR (CDCl3, 300 MHz) d (ppm): 10.10 (s, 1H, -CHO), 8.09 (d, J = 6.0 Hz, 1H, ArH), 8.05 (d, J = 6.0 Hz, 1H, ArH), 7.75 (s, 1H, ArH), 7.67 (s, 1H, ArH), 7.31 (br, 2H, ArH), 7.29-7.27 (m, 4H, ArH), 7.17-7.04 (m, 8H, ArH), 3.02 (t, J = 6.0 Hz, 2H, -CH2-), 2.83 (br, 6H, -CH3), 2.72 (t, J = 6.0 Hz, 2H, -CH2-), 1.76-1.68 (m, 4H, -CH2-), 1.39-1.26 (m, 12H, -CH2-), 0.90-0.81 (m, 6H, -CH3).
3-Hexyl-5-(8-(4-hexyl-5-(9-hexyl-9H-carbazol-3-yl)thiophen-2-yl)-2,3-dimethylquinoxalin-5-yl) thiophene-2-carbaldehyde (5b). Red solid. 0.57 g. Yield: 76%. 1H NMR (CDCl3, 300 MHz) d (ppm): 10.10 (s, 1H, -CHO), 8.24 (br, 1H, ArH), 8.12 (br, 1H, ArH), 8.04 (br, 2H, ArH), 7.81 (br, 2H, ArH), 7.66 (s, 1H, ArH), 7.47 (s, 1H, ArH), 7.44 (br, 1H, ArH), 7.34 (s, 1H, ArH), 7.25 (br, 1H, ArH), 4.32 (br, 2H, -CH2-), 2.98 (br, 2H, -CH2-), 2.79 (br, 6H, -CH3), 2.73 (br, 2H, -CH2-), 1.90-1.66 (m, 6H, -CH2-), 1.33 (br, 18H, -CH2-), 0.88 (br, 9H, -CH3).
4,7-Bis(4-hexylthiophen-2-yl)benzo[c] [1,
2,
5]oxadiazole (6). The syntheses of
6 was followed the same procedure as that of compound
2 using appropriate compounds. Red oil. 1.49 g. Yield: 87%.
1H NMR (CDCl
3, 300 MHz)
d (ppm): 7.96 (s, 2H, ArH), 7.56 (br, 2H, ArH), 7.03 (s, 2H, ArH), 2.68 (t,
J = 7.5 Hz, 4H, -CH
2-), 1.71-1.61 (m, 4H, -CH
2-), 1.39-1.32 (m, 12H, -CH
2-), 0.95-0.90 (m, 6H, -CH
3).
3-Hexyl-5-(7-(4-hexylthiophen-2-yl)benzo[c] [1,
2,
5]oxadiazol-4-yl)thiophene-2-carbaldehyde (7). The syntheses of
7 was followed the same procedure as that of compound
3 using appropriate compounds. Red solid. 1.02 g. Yield: 85%.
1H NMR (CDCl
3, 300 MHz)
d (ppm): 10.11 (s, 1H, -CHO), 8.06 (s, 1H, ArH), 8.04 (s, 1H, ArH), 7.72 (br, 1H, ArH), 7.62 (br, 1H, ArH), 7.09 (s, 1H, ArH), 3.03 (t,
J = 6.0 Hz, 2H, -CH
2-), 3.03 (t,
J = 6.3 Hz, 2H, -CH
2-), 1.85-1.71 (m, 4H, -CH
2-), 1.34 (br, 12H, -CH
2-), 0.92-0.89 (m, 6H, -CH
3).
5-(7-(5-Bromo-4-hexylthiophen-2-yl)benzo[c] [1,
2,
5]oxadiazol-4-yl)-3-hexylthiophene-2-carbalde hyde (8). The syntheses of
8 was followed the same procedure as that of compound
4 using appropriate compounds. Red solid. 0.74 g. Yield: 81%.
1H NMR (CDCl
3, 300 MHz)
d (ppm): 10.10 (s, 1H, -CHO), 8.05 (s, 1H, ArH), 7.87 (s, 1H, ArH), 7.72 (d,
J = 7.2 Hz, 1H, ArH), 7.51 (d,
J = 7.8 Hz, 1H, ArH), 3.02 (t,
J = 7.5 Hz, 2H, -CH
2-), 2.63 (t,
J = 7.8 Hz, 2H, -CH
2-), 1.76-1.63 (m, 4H, -CH
2-), 1.39-1.25 (m, 12H, -CH
2-), 0.90 (br, 6H, -CH
3).
General synthesis of 9. The syntheses of 9 was followed the same procedure as that of compound 5 using appropriate compounds.
5-(7-(5-(4-(Diphenylamino)phenyl)-4-hexylthiophen-2-yl)benzo[c] [1,
2,
5]oxadiazol-4-yl)-3-hexyl thiophene-2-carbaldehyde (9a). Red solid. 0.53 g. Yield: 73%.
1H NMR (CDCl
3, 300 MHz)
d (ppm): 10.10 (s, 1H, -CHO), 8.08 (s, 1H, ArH), 8.05 (s, 1H, ArH), 7.73 (d,
J = 7.2 Hz, 1H, ArH), 7.58 (d,
J = 7.6 Hz, 1H, ArH), 7.37-7.29 (m, 6H, ArH), 7.17- 7.04 (m, 8H, ArH), 3.01 (t,
J = 7.2 Hz, 2H, -CH
2-), 2.74 (t,
J = 8.4 Hz, 2H, -CH
2-), 1.76-1.71 (m, 4H, -CH
2-), 1.31 (br, 12H, -CH
2-), 0.89 (br, 6H, -CH
3).
3-Hexyl-5-(7-(4-hexyl-5-(9-hexyl-9H-carbazol-3-yl)thiophen-2-yl)benzo[c] [1,
2,
5]oxadiazol-4-yl) thiophene-2-carbaldehyde (9b). Red solid. 0.49 g. Yield: 77%.
1H NMR (CDCl
3, 300 MHz)
d (ppm): 10.10 (s, 1H, -CHO), 8.22 (br, 1H, ArH), 8.13 (br, 1H, ArH), 8.11 (s, 1H, ArH), 8.06 (s, 1H, ArH), 7.75 (d,
J = 7.2 Hz, 1H, ArH), 7.63-7.59 (m, 2H, ArH), 7.51-7.43 (m, 4H, ArH), 4.34 (t,
J = 7.2 Hz, 2H, -CH
2-), 3.01 (t,
J = 8.1 Hz, 2H, -CH
2-), 2.79 (t,
J = 7.8 Hz, 2H, -CH
2-), 1.91-1.69 (m, 6H, -CH
2-), 1.33-1.25 (m, 18H, -CH
2-), 0.90-0.85 (m, 9H, -CH
3).
General synthesis of organic dyes. A mixture of 5 or 9 (0.25 mmol) and cyanoacetic acid (85 mg, 1.0 mmol) were vacuum-dried, then MeCN (15.0 mL), THF (5.0 mL) and piperidine (10 mL) were added. The solution was refluxed for 8 h. After the solution was cooled, the organic layer was removed under vacuum. The product was purified by column chromatography.
2-Cyano-3-(5-(8-(5-(4-(diphenylamino)phenyl)-4-hexylthiophen-2-yl)-2,3-dimethyl-2,3-dihydro quinoxalin-5-yl)-3-hexylthiophen-2-yl)acrylic acid (LI-44). Red solid. 0.14 g. Yield: 68%. 1H NMR (DMSO-d6, 300 MHz) d (ppm): 8.29-8.24 (m, 2H, ArH), 8.16 (br, 1H, -CH= ), 7.91 (br, 1H, ArH), 7.89 (br, 1H, ArH), 7.39-7.29 (m, 6H, ArH), 7.09-6.99 (m, 8H, ArH), 2.73 (br, 6H,-CH3), 2.67 (br, 4H, -CH2-), 1.61 (br, 4H, -CH2-), 1.27-1.24 (m, 12H, -CH2-), 0.84-0.82 (m, 6H, -CH3). 13C NMR (DMSO-d6, 75 MHz) d (ppm): 165.16, 156.62, 156.47, 153.19, 147.57, 147.09, 146.18, 142.14, 137.71, 136.57, 135.58, 133.39, 131.75, 130.23, 130.07, 128.86, 127.49, 126.28, 124.89, 124.00, 123.33, 117.87, 31.69, 31.12, 30.88, 29.27, 28.86, 28.51, 22.75, 14.59. MS (EI), m/z [M]: 828.38, (calcd: 828.35). Anal. Calcd for: C52H52N4O2S2: C, 75.33; H, 6.32; N, 6.76. Found: C, 75.08; H, 6.80; N, 6.73.
2-Cyano-3-(3-hexyl-5-(8-(4-hexyl-5-(9-hexyl-9H-carbazol-3-yl)thiophen-2-yl)-2,3-dimethyl quinoxalin-5-yl)thiophen-2-yl)acrylic acid (LI-45). Red solid. 0.16 g. Yield: 74%. 1H NMR (DMSO-d6, 300 MHz) d (ppm): 8.34-8.29 (m, 2H, ArH), 8.24-8.18 (m, 3H, ArH and-CH= ), 7.96 (br, 2H, ArH), 7.67-7.47 (m, 4H, ArH), 7.17 (br, 1H, ArH), 4.25 (t, J = 6.6 Hz, 2H, -CH2-), 2.41 (t, J = 7.5 Hz, 2H, -CH2-), 2.13 (t, J = 7.8 Hz, 2H, -CH2-), 1.77 (br, 2H, -CH2-), 1.64 (br, 4H, -CH2-), 1.28-1.20 (m, 18H, -CH2-), 0.84-0.75 (m, 9H, -CH3). 13C NMR (DMSO-d6, 75 MHz) d (ppm): 160.12, 152.68, 145.55, 143.55, 142.31, 141.03, 139.94, 137.65, 136.65, 135.79, 133.67, 130.12, 129.86, 129.54, 127.37, 126.45, 125.65, 122.94, 122.71, 120.84, 119.44, 119.05, 109.59, 103.03, 31.79, 31.36, 29.36, 29.18, 26.98, 22.83, 14.50. MS (EI), m/z [M]: 834.67, (calcd: 834.40). Anal. Calcd for: C52H60N4O2S2: C, 74.78; H, 7.00; N, 6.71. Found: C, 74.31; H, 6.93; N, 6.34.
2-Cyano-3-(5-(7-(5-(4-(diphenylamino)phenyl)-4-hexylthiophen-2-yl)benzo[c] [1,
2,
5]oxadiazol-4-yl) -
3-hexylthiophen-2-yl)acrylic acid (LI-46). Black solid. 0.17 g. Yield: 84%.
1H NMR (DMSO-
d6, 300 MHz)
d (ppm): 8.19 (s, 1H, -CH= ), 7.94 (s, 1H, ArH), 7.89 (s, 1H, ArH), 7.86 (br, 1H, ArH), 7.73 (d,
J = 7.2 Hz, 1H, ArH), 7.35-7.31 (m, 6H, ArH), 7.12-6.97 (m, 8H, ArH), 2.77 (br, 3H, -CH
3), 2.63 (br, 3H, -CH
3), 2.41 (t,
J = 7.2 Hz, 2H, -CH
2-), 2.13 (t,
J = 8.1 Hz, 2H, -CH
2-), 1.60 (br, 4H, -CH
2-), 1.30-1.25 (m, 12H, -CH
2-), 0.85-0.83 (m, 6H, -CH
3).
13C NMR (DMSO-
d6, 75 MHz)
d (ppm): 160.13, 151.19, 145.51, 145.19, 138.82, 137.76, 132.37, 130.08, 129.57, 128.02, 127.97, 127.71, 127.04, 125.07, 122.96, 121.79, 120.86, 120.40, 117.13, 31.56, 30.93, 30.68, 29.20, 29.05, 28.91, 27.88, 22.61, 22.23, 14.33. MS (EI), m/z [M]: 790.21, (calcd: 790.30). Anal. Calcd for: C
48H
46N
4O
3S
2: C, 72.88; H, 5.86; N, 7.08. Found: C, 72.49; H, 6.04; N, 6.79.
2-Cyano-3-(3-hexyl-5-(7-(4-hexyl-5-(9-hexyl-9H-carbazol-3-yl)thiophen-2-yl)benzo[c] [1,
2,
5] oxadiazol-4-yl)thiophen-2-yl)acrylic acid (LI-47). Black solid. 0.14 g. Yield: 74%.
1H NMR (DMSO-
d6, 300 MHz)
d (ppm): Red solid. 0.14 g. Yield: 69%. 8.17-8.11 (m, 3H, ArH and-CH= ), 7.91 (s, 1H, ArH), 7.83 (s, 1H, ArH), 7.77 (d,
J = 7.5 Hz, 1H, ArH), 7.67 (d,
J = 6.6 Hz, 1H, ArH), 7.55 (br, 2H, ArH), 7.48 (s, 1H, ArH), 7.45 (s, 1H, ArH), 7.18 (d,
J = 7.2 Hz, 1H, ArH), 4.34 (br, 2H, -CH
2-), 2.75 (br, 2H, -CH
2-), 2.65 (br, 2H, -CH
2-), 1.74 (br, 2H, -CH
2-), 1.60 (br, 4H, -CH
2-), 1.29-1.83 (m, 18H, -CH
2-), 0.85-0.74 (m, 9H, -CH
3).
13C NMR (DMSO-
d6, 75 MHz)
d (ppm): 161.21, 152.61, 147.36, 142.14, 140.78, 139.86, 139.47, 134.36, 131.96, 130.04, 127.10, 126.79, 126.33, 124.22, 122.76, 122.32, 120.61, 119.29, 109.43, 102.30, 31.44, 30.99, 30.71, 29.15, 28.88, 26.69, 22.52, 14.19. MS (EI), m/z [M]: 796.42, (calcd: 796.35). Anal. Calcd for: C
48H
52N
4O
3S
2: C, 72.33; H, 6.58; N, 7.03. Found: C, 72.09; H, 6.75; N, 6.98.